Literature DB >> 17539918

An in vitro model of aneurysmal subarachnoid hemorrhage: oxidation of unconjugated bilirubin by cytochrome oxidase.

Matthew C Loftspring1, William L Wurster1, Gail J Pyne-Geithman1, Joseph F Clark1.   

Abstract

Aneurysmal subarachnoid hemorrhage is a stroke subtype with high rates of mortality and morbidity. Cerebral vasospasm can lead to ischemic injury or death and is a common complication of aneurysmal subarachnoid hemorrhage, usually occurring 3-9 days afterwards. The cause of vasospasm is not known. Recently, there has been strong evidence that vasoactive oxidation products of bilirubin may be involved. Currently, the factors that lead to bilirubin oxidation are poorly characterized. In this study, we have designed an in vitro model of hemorrhagic stroke in order to investigate conditions that promote the oxidation of bilirubin to form vasoactive compounds. Using our model, we created a basic hematoma system of blood, CSF, and hemeoxygenase-1. We manipulated this system in various ways, incubated it and determined the concentration of vasoactive bilirubin oxidation products that resulted. Conditions where cytochrome oxidase was stimulated caused an increase bilirubin oxidation products (292.6 +/- 39.9 micromol/L respectively, vs. 79.3 +/- 1.3 micromol/L for the basic reaction, p < 0.05), which was attenuated by cyanide. Our data suggest that bilirubin oxidation products may be produced by oxidation(s) requiring an oxygen-utilizing enzyme like cytochrome oxidase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539918     DOI: 10.1111/j.1471-4159.2007.04667.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  A preliminary study of metalloproteins in CSF by CapLC-ICPMS and NanoLC-CHIP/ITMS.

Authors:  Jenny Ellis; Estela Del Castillo; Maria Montes Bayon; Rudolf Grimm; Joseph F Clark; Gail Pyne-Geithman; Steve Wilbur; Joseph A Caruso
Journal:  J Proteome Res       Date:  2008-07-29       Impact factor: 4.466

2.  A novel brain injury mechanism after intracerebral hemorrhage: the interaction between heme products and the immune system.

Authors:  Matthew C Loftspring; Craig Hansen; Joseph F Clark
Journal:  Med Hypotheses       Date:  2009-08-28       Impact factor: 1.538

3.  Bilirubin and its oxidation products damage brain white matter.

Authors:  Katarina Lakovic; Jinglu Ai; Josephine D'Abbondanza; Asma Tariq; Mohammed Sabri; Abdullah K Alarfaj; Punarjot Vasdev; Robert Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-27       Impact factor: 6.200

4.  Bilirubin oxidation products, oxidative stress, and intracerebral hemorrhage.

Authors:  J F Clark; M Loftspring; W L Wurster; S Beiler; C Beiler; K R Wagner; G J Pyne-Geithman
Journal:  Acta Neurochir Suppl       Date:  2008

5.  Non-Animal Models in Experimental Subarachnoid Hemorrhage Research: Potentials and the Dilemma of the Translation from Bench to Bedside.

Authors:  Cihat Karadag; Jay Gopalakrishnan; Christiane von Saß; Jan F Cornelius; Daniel Hänggi; Jasper Hans van Lieshout; Marcel A Kamp
Journal:  Transl Stroke Res       Date:  2021-10-29       Impact factor: 6.829

6.  Impact of heme and heme degradation products on vascular diameter in mouse visual cortex.

Authors:  Alexander Joerk; Raphael Andreas Seidel; Sebastian Gottfried Walter; Anne Wiegand; Marcel Kahnes; Maurice Klopfleisch; Knut Kirmse; Georg Pohnert; Matthias Westerhausen; Otto Wilhelm Witte; Knut Holthoff
Journal:  J Am Heart Assoc       Date:  2014-08-28       Impact factor: 5.501

7.  Recombinant human brain-derived neurotrophic factor prevents neuronal apoptosis in a novel in vitro model of subarachnoid hemorrhage.

Authors:  Mingchang Li; Yuefei Wang; Wei Wang; Changlin Zou; Xin Wang; Qianxue Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2017-04-03       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.